Skip to Main Content
Aiko Yamada
Aiko Yamada

Aiko Yamada

Counsel
Tokyo
+81.3.6205.3630
Email Aiko Yamada @ Aiko.Yamada@klgates.com
Download V-Card
Download Aiko Yamada PDF (English)
Download Aiko Yamada PDF (Japanese)

Aiko Yamada is a counsel and a member of the firm's Corporate Mergers and Acquisitions; Data Protection, Privacy, and Security; Emerging Growth and Venture Capital; Healthcare and FDA; and Technology Transactions and Sourcing practice groups.

Aiko has over two decades experience in the legal profession. She has represented a broad range of clients with a focus on global pharmaceutical companies, global medical device companies, Japanese and US biotechnology companies, but also including global mobile telecommunications and IT companies and Japanese trading companies.

REPRESENTATIVE EXPERIENCE

Aiko was admitted to practice law in Japan in 2000 and the state of New York in 2007, she joined the firm in 2020.

Prior to joining the firm, she served as a counsel at a multinational law firm for 20 years, where she gained experience in structuring, negotiating, and implementing various business and finance transactions. She focused her work on mergers and acquisitions and investment transactions, including both domestic and cross-border deals, compliance and corporate governance, and general corporate counseling. She also focused her work on policy and regulatory enforcement in the pharmaceuticals, biologics and medical devices industry and the technology and telecom industry, including regulatory and compliance advice on digital health, Medtech, AI, blockchain, cybersecurity and privacy, Fintech, data analytics, and software and app development.

  • Recognized in The Best Lawyers in Japan™ for International Business Transactions, 2024-2025
  • Recognized by Chambers Asia-Pacific for Life Sciences in Japan, 2018-2019
  • Research Committee on the Judicial System, Dai-ichi Tokyo Bar Association
  • Legal and regulatory issues in the life sciences and healthcare industry (Financial Management Forums, Inc., December 2016)
  • Legal and business issues on medical big data and gene and cell remedies (Financial Management Forums, Inc., May 2017)
Additional Thought Leadership Pages
Additional News & Event Pages
Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel